scholarly journals OASIS evaluation of the French surveillance network for antimicrobial resistance in diseased animals (RESAPATH): success factors underpinning a well-performing voluntary system

2021 ◽  
pp. 1-29
Author(s):  
R. Mader ◽  
N. Jarrige ◽  
M. Haenni ◽  
C. Bourély ◽  
J.-Y. Madec ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Success Factors ◽  
Surveillance Network

scholarly journals OASIS evaluation of the French surveillance network for antimicrobial resistance in diseased animals (RESAPATH): success factors at the basis of a well-performing volunteer system

2021 ◽  
Author(s):  
R. Mader ◽  
N. Jarrige ◽  
M. Haenni ◽  
C. Bourély ◽  
J.-Y. Madec ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Success Factors ◽  
One Health ◽  
Assessment Tool ◽  
Data Management System ◽  
Surveillance Systems ◽  
Surveillance Network ◽  
Performance Factors ◽  
Volunteer Participation ◽  
Institutional Organization

SummaryAntimicrobial resistance is a One Health issue requiring the development of surveillance systems in the human, environmental and animal sectors. In Europe, the surveillance of antimicrobial resistance on zoonotic pathogens and indicator bacteria in healthy food-producing animals has been implemented on a legal basis, while countries are also expected to extend their surveillance to diseased animals in the frame of national action plans. In this context, evaluating existing antimicrobial resistance surveillance systems in veterinary medicine is important to improve systems in place, but also to help other countries learn from these experiences, understand success factors and anticipate challenges. With this aim, the French surveillance network for antimicrobial resistance in bacteria from diseased animals (RESAPATH) was evaluated using the OASIS assessment tool. Key performance factors included (i) a strong and inclusive central institutional organization defining clear and well-accepted surveillance objectives, scope and procedures, (ii) strong skills in epidemiology and microbiology and (iii) a win-win approach enabling the volunteer participation of 71 field laboratories and where a free annual proficiency testing plays a pivotal role. The main area of improvement of RESAPATH was its time-consuming data management system.

scholarly journals Building the European Antimicrobial Resistance Surveillance network in veterinary medicine (EARS-Vet)

2021 ◽  
Vol 26 (4) ◽  
Author(s):  
Rodolphe Mader ◽  
Peter Damborg ◽  
Jean-Philippe Amat ◽  
Björn Bengtsson ◽  
Clémence Bourély ◽  
...  
Keyword(s):  
Veterinary Medicine ◽  
Antimicrobial Resistance ◽  
Antimicrobial Stewardship ◽  
One Health ◽  
Action Plan ◽  
Animal Health ◽  
World Health ◽  
European Economic Area ◽  
Surveillance Network ◽  
Antimicrobial Resistance Surveillance

Antimicrobial resistance (AMR) should be tackled through a One Health approach, as stated in the World Health Organization Global Action Plan on AMR. We describe the landscape of AMR surveillance in the European Union/European Economic Area (EU/EEA) and underline a gap regarding veterinary medicine. Current AMR surveillance efforts are of limited help to veterinary practitioners and policymakers seeking to improve antimicrobial stewardship in animal health. We propose to establish the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) to report on the AMR situation, follow AMR trends and detect emerging AMR in selected bacterial pathogens of animals. This information could be useful to advise policymakers, explore efficacy of interventions, support antimicrobial stewardship initiatives, (re-)evaluate marketing authorisations of antimicrobials, generate epidemiological cut-off values, assess risk of zoonotic AMR transmission and evaluate the burden of AMR in animal health. EARS-Vet could be integrated with other AMR monitoring systems in the animal and medical sectors to ensure a One Health approach. Herein, we present a strategy to establish EARS-Vet as a network of national surveillance systems and highlight challenges of data harmonisation and bias. Strong political commitment at national and EU/EEA levels is required for the success of EARS-Vet.

scholarly journals Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018

2019 ◽  
Vol 24 (46) ◽  
Author(s):  
Germán Peñalva ◽  
Liselotte Diaz Högberg ◽  
Klaus Weist ◽  
Vera Vlahović-Palčevski ◽  
Ole Heuer ◽  
...  
Keyword(s):  
European Union ◽  
Antimicrobial Resistance ◽  
European Economic Area ◽  
Segmented Regression ◽  
The European Union ◽  
Antimicrobial Consumption ◽  
Surveillance Network ◽  
The Public ◽  
Early Indication ◽  
Health Agenda

Investments to reduce the spread of antimicrobial resistance (AMR) in the European Union have been made, including efforts to strengthen prudent antimicrobial use. Using segmented regression, we report decreasing and stabilising trends in data reported to the European Surveillance of Antimicrobial Consumption Network and stabilising trends in data reported to the European Antimicrobial Resistance Surveillance Network. Our results could be an early indication of the effect of prioritising AMR on the public health agenda.

scholarly journals ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance

2020 ◽  
Vol 5 ◽  
pp. 13
Author(s):  
Paul Turner ◽  
Elizabeth A. Ashley ◽  
Olivier J. Celhay ◽  
Anousone Douangnouvong ◽  
Raph L. Hamers ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Treatment Guidelines ◽  
Clinical Care ◽  
Local Treatment ◽  
Laboratory Data ◽  
Added Value ◽  
Pilot Phase ◽  
Surveillance Network ◽  
Antimicrobial Resistance Surveillance ◽  
The Impact

Background: Antimicrobial resistance (AMR) / drug resistant infections (DRIs) are a major global health priority. Surveillance data is critical to inform infection treatment guidelines, monitor trends, and to assess interventions. However, most existing AMR / DRI surveillance systems are passive and pathogen-based with many potential biases. Addition of clinical and patient outcome data would provide considerable added value to pathogen-based surveillance. Methods: The aim of the ACORN project is to develop an efficient clinically-oriented AMR surveillance system, implemented alongside routine clinical care in hospitals in low- and middle-income country settings. In an initial pilot phase, clinical and microbiology data will be collected from patients presenting with clinically suspected meningitis, pneumonia, or sepsis. Community-acquired infections will be identified by daily review of new admissions, and hospital-acquired infections will be enrolled during weekly point prevalence surveys, on surveillance wards. Clinical variables will be collected at enrolment, hospital discharge, and at day 28 post-enrolment using an electronic questionnaire on a mobile device. These data will be merged with laboratory data onsite using a flexible automated computer script. Specific target pathogens will be Streptococcus pneumoniae, Staphylococcus aureus, Salmonella spp., Klebsiella pneumoniae, Escherichia coli, and Acinetobacter baumannii. A bespoke browser-based app will provide sites with fully interactive data visualisation, analysis, and reporting tools. Discussion: ACORN will generate data on the burden of DRI which can be used to inform local treatment guidelines / national policy and serve as indicators to measure the impact of interventions. Following development, testing and iteration of the surveillance tools during an initial six-month pilot phase, a wider rollout is planned.

scholarly journals National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands

2017 ◽  
Vol 22 (46) ◽  
Author(s):  
Wieke Altorf-van der Kuil ◽  
Annelot F Schoffelen ◽  
Sabine C de Greeff ◽  
Steven FT Thijsen ◽  
H Jeroen Alblas ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
The Netherlands ◽  
Surveillance System ◽  
Data Transfer ◽  
National Laboratory ◽  
Temporal Trends ◽  
Routine Data ◽  
Healthcare Services ◽  
Background Information ◽  
Surveillance Network

An important cornerstone in the control of antimicrobial resistance (AMR) is a well-designed quantitative system for the surveillance of spread and temporal trends in AMR. Since 2008, the Dutch national AMR surveillance system, based on routine data from medical microbiological laboratories (MMLs), has developed into a successful tool to support the control of AMR in the Netherlands. It provides background information for policy making in public health and healthcare services, supports development of empirical antibiotic therapy guidelines and facilitates in-depth research. In addition, participation of the MMLs in the national AMR surveillance network has contributed to sharing of knowledge and quality improvement. A future improvement will be the implementation of a new semantic standard together with standardised data transfer, which will reduce errors in data handling and enable a more real-time surveillance. Furthermore, the scientific impact and the possibility of detecting outbreaks may be amplified by merging the AMR surveillance database with databases from selected pathogen-based surveillance programmes containing patient data and genotypic typing data.

scholarly journals The Enter-net international surveillance network – how it works

1999 ◽  
Vol 4 (5) ◽  
pp. 52-55 ◽  
Author(s):  
I. S.T. Fisher ◽  
Keyword(s):  
Escherichia Coli ◽  
Antimicrobial Resistance ◽  
Gastrointestinal Infections ◽  
Surveillance Network ◽  
International Network

Enter-net is an international network for the surveillance of human gastrointestinal infections, which monitors salmonellosis and Vero cytotoxin producing Escherichia coli (VTEC) O157, including their antimicrobial resistance. When the network began it in

scholarly journals Antimicrobial resistance in UK neonatal units: neonIN infection surveillance network

2017 ◽  
Vol 103 (5) ◽  
pp. F474-F478 ◽  
Author(s):  
Benjamin Cailes ◽  
Christina Kortsalioudaki ◽  
Jim Buttery ◽  
Santosh Pattnayak ◽  
Anne Greenough ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Late Onset ◽  
Future Research ◽  
Surveillance Network ◽  
Infection Surveillance ◽  
Late Onset Sepsis ◽  
Early Onset Sepsis ◽  
The Common ◽  
The Uk ◽  
Evidence Based Guidelines

ObjectiveTo define the susceptibilities of the common causative pathogens of neonatal sepsis in the UK.DesignRetrospective analysis of the prospectively collected neonIN infection surveillance network data between 2005 and 2014.Setting30 neonatal units in the UK.PatientsNewborns admitted to participating neonatal units who return a positive blood, cerebrospinal fluid or urine culture and are treated with at least 5 days of appropriate antibiotics.Results1568 isolates with recorded antimicrobial data were collected including 328 early-onset sepsis (EOS) isolates and 1240 late-onset sepsis (LOS) isolates. The majority of EOS pathogens (>92%) were susceptible to the four empirical commonly used antimicrobial combinations (eg, 93% for benzylpenicillin/gentamicin), while LOS pathogens demonstrated higher levels of resistance (eg, 89% for flucloxacillin/gentamicin). Among infants<1500 g and <32 weeks gestation, an amoxicillin/gentamicin combination demonstrated a trend towards improved coverage of EOS isolates than benzylpenicillin/gentamicin (93% vs 86%, p=0.211).ConclusionsThis analysis provides insights into the patterns of antimicrobial resistance among UK neonatal pathogens. These data will inform areas of future research and can be used to update national evidence-based guidelines on antimicrobial usage.

scholarly journals In VitroAntimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010

2012 ◽  
Vol 56 (4) ◽  
pp. 2181-2183 ◽  
Author(s):  
Guillermo V. Sanchez ◽  
Ronald N. Master ◽  
James A. Karlowsky ◽  
Jose M. Bordon
Keyword(s):  
Escherichia Coli ◽  
Antimicrobial Resistance ◽  
Antimicrobial Susceptibility ◽  
Minimal Change ◽  
Urine Samples ◽  
Surveillance Network ◽  
Content Type ◽  
E Coli ◽  
Resistance Data

ABSTRACTThis study examinesin vitroantimicrobial resistance data fromEscherichia coliisolates obtained from urine samples of U.S. outpatients between 2000 and 2010 using The Surveillance Network (TSN). Antimicrobial susceptibility results (n= 12,253,679) showed the greatest increases inE. coliresistance from 2000 to 2010 for ciprofloxacin (3% to 17.1%) and trimethoprim-sulfamethoxazole (TMP-SMX) (17.9% to 24.2%), whereas nitrofurantoin (0.8% to 1.6%) and ceftriaxone (0.2% to 2.3%) showed minimal change. From 2000 to 2010, the antimicrobial resistance of urinaryE. coliisolates to ciprofloxacin and TMP-SMX among outpatients increased substantially.

Sign in / Sign up

Export Citation Format

Share Document